Global Rapid Influenza Diagnostic Test (RIDT) Market Growth (Status and Outlook) 2024-2030

Global Rapid Influenza Diagnostic Test (RIDT) Market Growth (Status and Outlook) 2024-2030

The global Rapid Influenza Diagnostic Test (RIDT) market size is projected to grow from US$ 1030 million in 2024 to US$ 1855 million in 2030; it is expected to grow at a CAGR of 10.3% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Rapid Influenza Diagnostic Test (RIDT) Industry Forecast” looks at past sales and reviews total world Rapid Influenza Diagnostic Test (RIDT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Influenza Diagnostic Test (RIDT) sales for 2023 through 2029. With Rapid Influenza Diagnostic Test (RIDT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Influenza Diagnostic Test (RIDT) industry.

This Insight Report provides a comprehensive analysis of the global Rapid Influenza Diagnostic Test (RIDT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rapid Influenza Diagnostic Test (RIDT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Influenza Diagnostic Test (RIDT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Influenza Diagnostic Test (RIDT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Influenza Diagnostic Test (RIDT).

In China, the key players of Rapid Influenza Diagnostic Test (RIDT) include Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Abbott, etc. The top three players hold a share of more than 61 percent. In terms of product type, Conventional RIDT is the largest segment, occupied for 92 percent. And in terms of application, hospital is the largest application, with a share of 65%.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Influenza Diagnostic Test (RIDT) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Digital RIDTs
Conventional RIDT

Segmentation by Application:
Hospital
POCT
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Digital RIDTs
Conventional RIDT

Segmentation by Application:
Hospital
POCT
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Quidel
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene

Please note: The report will take approximately 2 business days to prepare and deliver.